S2658Referred to Committee
Medication Affordability and Patent Integrity Act
Introduced
In Committee
3
Passed One Chamber4
Passed Both5
Signed into Law119th
Congress
2025-08-01
Introduced
1
Cosponsors
S
ⓘType
Sponsor
Margaret Wood Hassan
Democrat · NH · Senator
Votes with party: 49.1% (324 recorded votes)
Full profile: /officials/H001076
Source: Congress.gov · FEC
Cosponsors (1)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Plain-English Summary
This bill would allow the federal government to negotiate drug prices directly with pharmaceutical companies for Medicare patients, while also limiting how long companies can extend their patent protections to keep generic competitors off the market. The changes would aim to lower medication costs for seniors and other patients, though drug manufacturers would face reduced profits from their patents. The bill affects pharmaceutical companies, Medicare beneficiaries, and patients who rely on prescription medications.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Commerce
Full bill text is not yet cached locally.
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S4578Gateway to Careers Act of 2026Referred to Committee · 2026-05-20
- S4510Relief for Families of the Fallen ActReferred to Committee · 2026-05-13
- SRES687A resolution supporting the designation of the week of April 27 through May 1, 2026, as "National Specialized Instructional Support Personnel Appreciation Week".Referred to Committee · 2026-04-27
- S4332Medication Competition ActReferred to Committee · 2026-04-16